Hôpital François Mitterrand

Dijon 21000

0 studies enrolling now · 2 studies all time

What they study most

Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma, Relapsed Hodgkin Lymphoma

Studies at this site

• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed